Feminizing Treatment in Transgender Women and Non-binary Persons

Odense University Hospital100 enrolled

Overview

Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years, Outcomes regarding cardiovascular effects of hormone treatment.

Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years, Outcomes: Non-calcified and calcified plaque formation by contras coronary CT angiograms Heartfunction by ekko Cardiovaskular risk markers, f. eks. bp Markers of cardiovascular risk in blood and urine

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Transgenderism

Interventions

standard treatmentOTHER

starndard treatment for transgender women

Eligibility

Sex: MALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * assigned male at birth and eligeble for gender affirming feminizing treatment Exclusion Criteria: none \-

Locations (1)

OdenseUH

Odense, Denmark

RECRUITING

Outcomes

Primary Outcomes

coronary plaque formation

mm3

Time frame: 1 year

Central Contacts

Dorte Glintborg

CONTACT

+4565411807 dorte.glintborg@rsyd.dk

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.